• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    OKYO Pharma Limited - Ordinary Shares (NQ:OKYO)

    2.340 +0.260 (+12.50%)
    Streaming Delayed Price Updated: 12:36 PM EST, Jan 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 169,912
    Open 2.080
    Bid (Size) 2.310 (400)
    Ask (Size) 2.370 (100)
    Prev. Close 2.080
    Today's Range 2.080 - 2.490
    52wk Range 0.9016 - 3.349
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Friday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
    From OKYO Pharma LTD
    Via GlobeNewswire

    Performance

    YTD
    +4.9%
    +4.9%
    1 Month
    +11.4%
    +11.4%
    3 Month
    +7.3%
    +7.3%
    6 Month
    -16.1%
    -16.1%
    1 Year
    +125.0%
    +125.0%

    More News

    Read More
    News headline image
    OKYO Pharma to Ring the Opening Bell at Nasdaq
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Stock Rises After Company Outlines Development Pathway For Neuropathic Corneal Pain Drug ↗
    Via Stocktwits
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma to Present at OIS XV in San Diego
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma to Present at BIO-Europe 2025 in Vienna
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited
    Via ACCESS Newswire
    News headline image
    OKYO Pharma to Present at the Bio International Convention
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire

    Frequently Asked Questions

    Is OKYO Pharma Limited - Ordinary Shares publicly traded?
    Yes, OKYO Pharma Limited - Ordinary Shares is publicly traded.
    What exchange does OKYO Pharma Limited - Ordinary Shares trade on?
    OKYO Pharma Limited - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for OKYO Pharma Limited - Ordinary Shares?
    The ticker symbol for OKYO Pharma Limited - Ordinary Shares is OKYO on the Nasdaq Stock Market
    What is the current price of OKYO Pharma Limited - Ordinary Shares?
    The current price of OKYO Pharma Limited - Ordinary Shares is 2.340
    When was OKYO Pharma Limited - Ordinary Shares last traded?
    The last trade of OKYO Pharma Limited - Ordinary Shares was at 01/22/26 12:36 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.